P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Tag: Trofinetide

DAYBUE – Breaking News

Health Canada Approves Daybue! Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE (trofinetide) for the Treatment of Rett Syndrome.   DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare neurodevelopmental disorder…. Read More

Health Canada Accepts a New Drug Submission 

Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More